Honduras

For nearly 50 years, PATH has advanced women's and girls' health by designing solutions that meet women where they are—at home, in their communities, and through technologies that prioritize choice, control, and dignity.Across Latin America and the Caribbean, PATH partners with ministries of health, civil society, and communities to make care more accessible, equitable, and centered on women's needs—shifting toward solutions that bring essential services directly to women.This fact sheet provides an overview of PATH's women's health work in Latin America and the Caribbean.

The Digital Results Improve Vaccine Equity and Demand (DRIVE Demand) project worked with ministries of health in six countries to strengthen immunization systems and improve equitable vaccine access, uptake, and reach through digital and data tools.Strengthening immunization systems with digital and data toolsWith support from The Rockefeller Foundation, Digital Square at PATH launched the Digital Results Improve Vaccine Equity and Demand (DRIVE Demand) project in June 2022 to aid and inform efforts to increase vaccine demand and acceptance rates in six countries through digitally enabled interventions. The six countries chosen were Honduras, Mali, Tanzania, Thailand, Uganda, and Zambia. The project ended in June 2024.Read the press releaseThe project’s approach leveraged digital and data tools to drive more effective and proactive vaccine interventions in these countries while simultaneously addressing barriers to vaccination such as access, trust, and information sharing. DRIVE Demand is guided by The Rockefeller Foundation's focus on supporting iterative, country-driven, hyper-local efforts to increase demand for vaccination.

PATH is a leader in adapting health innovations with and for women across systems, populations, and geographies. This brief outlines PATH's vision, approach, and areas of expertise in Sexual and Reproductive Health.

This brief summarizes the experience and capabilities of the PATH Cervical Cancer Team. For decades, PATH has been at the forefront of evidence-based strategies from HPV vaccine research and delivery to cervical cancer screening and treatment to ensure we best meet the needs and realities of these countries for the greatest health impact.

Un modelo interactivo de Excel que evalúa las ventajas y desventajas de cuatro estrategias del tamizaje del cáncer cérvicouterino y cinco escenarios de tratamiento del precáncer cérvicouterino, al analizar la cantidad de mujeres alcanzadas, la eficacia del enfoque y los costos asociados. Haga clic en el enlace arriba para descargar el archivo Excel. CONSULTE LA NOTA ACLARATORIA EN LA HERRAMIENTA ANTES DE USAR.

Una hoja informativa que proporciona una descripción general de la Herramienta de Planificación para el Precáncer Cérvicouterino, incluidos los antecedentes, una descripción general de los escenarios y cómo la herramienta puede apoyar la planificación basada en evidencia.

A fact sheet that provides an overview of the Cervical Precancer Planning Tool, including the background, a scenario overview, and how the tool can support evidence-based planning.

An interactive Excel model that evaluates the trade-offs of four cervical cancer screening approaches and five cervical precancer treatment scenarios, looking at number of women reached, effectiveness of approach, and associated costs. Click the above link to download the Excel file. SEE DISCLAIMER IN TOOL BEFORE USE.

Imagine you need treatment for cervical precancer.

PATH’s Scale-Up project seeked to reduce cervical cancer incidence through improved and expanded screening using human papillomavirus (HPV) testing. Between 2015 and 2020, PATH partnered with countries in Central America to implement HPV testing for cervical cancer screening within public sector clinics. The project demonstrated that a new model of cervical cancer screening anchored on HPV testing is achievable. This resource shares the key findings and public health implications.